Systems-Based Technologies in Profiling the Stem Cell Molecular Framework for Cardioregenerative Medicine

Stem Cell Reviews and Reports

Volumn 11, Issue 3, 2015, Pages 501-510

  Wyles, Saranya P ^a,b   Faustino, Randolph S ^b   Li, Xing ^b,c   Terzic, Andre ^b,c   Nelson, Timothy J ^a,b,c,d  

^a Center for Clinical and Translational Sciences   (United States)

^b Center for Regenerative Medicine   (United States)

^c Department of Medicine ^*  (United States)

^d Mayo Clinic College of Medicine   (United States)

Author keywords

Cardiac Regeneration; OMICS; Stem Cells; Systems Biology

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 6; NODAL SIGNALING PROTEIN; NOTCH RECEPTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR GATA 4; WNT PROTEIN;

ACUTE HEART INFARCTION; ARTICLE; CARDIOREGENERATIVE MEDICINE; CELL FATE; CHROMATIN IMMUNOPRECIPITATION; EMBRYONIC STEM CELL; EPITHELIAL MESENCHYMAL TRANSITION; HEART DEVELOPMENT; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; METABOLOMICS; NEOVASCULARIZATION (PATHOLOGY); OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RECURRENT DISEASE; REGENERATIVE MEDICINE; STEM CELL; TANDEM MASS SPECTROMETRY; TRANSCRIPTOMICS; CARDIOVASCULAR SYSTEM; CYTOLOGY; GENOMICS; METABOLISM; PATHOLOGY; SYSTEMS BIOLOGY;

CARDIOVASCULAR SYSTEM; GENOMICS; HUMANS; METABOLOMICS; PROTEOMICS; REGENERATIVE MEDICINE; STEM CELLS; SYSTEMS BIOLOGY;

EID: 84930614073     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-014-9557-5     Document Type: Article

References (105)

1. Westerhoff, H. V., & Palsson, B. O. (2004). The evolution of molecular biology into systems biology. Nature Biotechnology, 22(10), 1249–1252.
2. Joyce, A. R., & Palsson, B. O. (2006). The model organism as a system: integrating ‘omics’ data sets. Nature Reviews Molecular Cell Biology, 7(3), 198–210.
3. Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., Gifford, D. K., Melton, D. A., Jaenisch, R., & Young, R. A. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 122(6), 947–956.
4. Kim, J., Chu, J., Shen, X., Wang, J., & Orkin, S. H. (2008). An extended transcriptional network for pluripotency of embryonic stem cells. Cell, 132(6), 1049–1061.
5. Wang, J., Rao, S., Chu, J., Shen, X., Levasseur, D. N., Theunissen, T. W., & Orkin, S. H. (2006). A protein interaction network for pluripotency of embryonic stem cells. Nature, 444(7117), 364–368.
6. Lu, R., Markowetz, F., Unwin, R. D., Leek, J. T., Airoldi, E. M., MacArthur, B. D., Lachmann, A., Rozov, R., Ma'ayan, A., Boyer, L. A., Troyanskaya, O. G., Whetton, A. D., & Lemischka, I. R. (2009). Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature, 462(7271), 358–362.
7. Horak, C. E., & Snyder, M. (2002). ChIP-chip: a genomic approach for identifying transcription factor binding sites. Methods in Enzymology, 350, 469–483.
8. de Boer, E., Rodriguez, P., Bonte, E., Krijgsveld, J., Katsantoni, E., Heck, A., Grosveld, F., & Strouboulis, J. (2003). Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 100(13), 7480–7485.
9. Chung, H., & Sidhu, K. S. (2008). Epigenetic modifications of embryonic stem cells: current trends and relevance in developing regenerative medicine. Stem Cells Cloning, 1, 11–21.
10. Fisher, C. L., & Fisher, A. G. (2011). Chromatin states in pluripotent, differentiated, and reprogrammed cells. Current Opinion in Genetics and Development, 21(2), 140–146.
11. Smith, C., & Storms, B. (2000). Hematopoietic stem cells. Clinical Orthopaedics and Related Research, 379, S91–97.
12. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., Leri, A., & Anversa, P. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410(6829), 701–705.
13. Murry, C. E., Soonpaa, M. H., Reinecke, H., Nakajima, H., Nakajima, H. O., Rubart, M., Pasumarthi, K. B., Virag, J. I., Bartelmez, S. H., Poppa, V., Bradford, G., Dowell, J. D., Williams, D. A., & Field, L. J. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 428(6983), 664–668.
14. Charbord, P., Pouget, C., Binder, H., Dumont, F., Stik, G., Levy, P., Allain, F., Marchal, C., Richter, J., Uzan, B., Pflumio, F., Letourneur, F., Wirth, H., Dzierzak, E., Traver, D., Jaffredo, T., & Durand, C. (2014). A Systems Biology Approach for Defining the Molecular Framework of the Hematopoietic Stem Cell Niche. Cell Stem: Cell.
15. Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., & Ho, A. D. (2005). Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Experimental Hematology, 33(11), 1402–1416.
16. Augello, A., & De Bari, C. (2010). The regulation of differentiation in mesenchymal stem cells. Human Gene Therapy, 21(10), 1226–1238.
17. Behfar, A., & Terzic, A. (2006). Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nature Clinical Practice. Cardiovascular Medicine, 3(Suppl 1), S78–82.
18. Liechty, K. W., MacKenzie, T. C., Shaaban, A. F., Radu, A., Moseley, A. M., Deans, R., Marshak, D. R., & Flake, A. W. (2000). Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Medicine, 6(11), 1282–1286.
19. Madonna, R., & De Caterina, R. (2010). Adipose tissue: a new source for cardiovascular repair. Journal of Cardiovascular Medicine (Hagerstown), 11(2), 71–80.
20. Meliga, E., Strem, B. M., Duckers, H. J., & Serruys, P. W. (2007). Adipose-derived cells. Cell Transplantation, 16(9), 963–970.
21. Planat-Benard, V., Silvestre, J. S., Cousin, B., Andre, M., Nibbelink, M., Tamarat, R., Clergue, M., Manneville, C., Saillan-Barreau, C., Duriez, M., Tedgui, A., Levy, B., Penicaud, L., & Casteilla, L. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation, 109(5), 656–663.
22. Carvalho, P. H., Daibert, A. P., Monteiro, B. S., Okano, B. S., Carvalho, J. L., Cunha, D. N., Favarato, L. S., Pereira, V. G., Augusto, L. E., & Del Carlo, R. J. (2013). Differentiation of adipose tissue-derived mesenchymal stem cells into cardiomyocytes. Arquivos Brasileiros de Cardiologia, 100(1), 82–89.
23. Peng, L., Jia, Z., Yin, X., Zhang, X., Liu, Y., Chen, P., Ma, K., & Zhou, C. (2008). Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells and Development, 17(4), 761–773.
24. Menicanin, D., Bartold, P. M., Zannettino, A. C., & Gronthos, S. (2009). Genomic profiling of mesenchymal stem cells. Stem Cell Reviews and Reports, 5(1), 36–50.
25. Solter, D. (2006). From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nature Reviews Genetics, 7(4), 319–327.
26. Evans, M. J., & Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292(5819), 154–156.
27. Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Sciences of the United States of America, 78(12), 7634–7638.
28. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147.
29. Wu, D. C., Boyd, A. S., & Wood, K. J. (2008). Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells, 26(8), 1939–1950.
30. Macarthur, B. D., Ma'ayan, A., & Lemischka, I. R. (2009). Systems biology of stem cell fate and cellular reprogramming. Nature Reviews Molecular Cell Biology, 10(10), 672–681.
31. Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., & Anversa, P. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6), 763–776.
32. Smith, R. R., Barile, L., Cho, H. C., Leppo, M. K., Hare, J. M., Messina, E., Giacomello, A., Abraham, M. R., & Marban, E. (2007). Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation, 115(7), 896–908.
33. Chong, J. J., Chandrakanthan, V., Xaymardan, M., Asli, N. S., Li, J., Ahmed, I., Heffernan, C., Menon, M. K., Scarlett, C. J., Rashidianfar, A., Biben, C., Zoellner, H., Colvin, E. K., Pimanda, J. E., Biankin, A. V., Zhou, B., Pu, W. T., Prall, O. W., & Harvey, R. P. (2011). Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell, 9(6), 527–540.
34. Ellison, G. M., Torella, D., Dellegrottaglie, S., Perez-Martinez, C., Perez de Prado, A., Vicinanza, C., Purushothaman, S., Galuppo, V., Iaconetti, C., Waring, C. D., Smith, A., Torella, M., Cuellas Ramon, C., Gonzalo-Orden, J. M., Agosti, V., Indolfi, C., Galinanes, M., Fernandez-Vazquez, F., & Nadal-Ginard, B. (2011). Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. Journal of the American College of Cardiology, 58(9), 977–986.
35. Mercola, M., Ruiz-Lozano, P., & Schneider, M. D. (2011). Cardiac muscle regeneration: lessons from development. Genes & Development, 25(4), 299–309.
36. Ellison, G. M., Torella, D., Karakikes, I., & Nadal-Ginard, B. (2007). Myocyte death and renewal: modern concepts of cardiac cellular homeostasis. Nature Clinical Practice. Cardiovascular Medicine, 4(Suppl 1), S52–59.
37. Torella, D., Ellison, G. M., & Nadal-Ginard, B. (2014). Adult c-kit (pos) cardiac stem cells fulfill Koch's postulates as causal agents for cardiac regeneration. Circulation Research, 114(4), e24–26.
38. van Berlo, J. H., Kanisicak, O., Maillet, M., Vagnozzi, R. J., Karch, J., Lin, S. C., Middleton, R. C., Marban, E., & Molkentin, J. D. (2014). c-kit + cells minimally contribute cardiomyocytes to the heart. Nature, 509(7500), 337–341.
39. Olson, E. N. (2004). A decade of discoveries in cardiac biology. Nature Medicine, 10(5), 467–474.
40. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676.
41. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861–872.
42. Park, I. H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451(7175), 141–146.
43. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917–1920.
44. Martinez-Fernandez, A., Nelson, T. J., Ikeda, Y., & Terzic, A. (2010). c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. Journal of Cardiovascular Translational Research, 3(1), 13–23.
45. Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120(5), 408–416.
46. Nelson, T. J., Behfar, A., Yamada, S., Martinez-Fernandez, A., & Terzic, A. (2009). Stem cell platforms for regenerative medicine. Clinical and Translational Science, 2(3), 222–227.
47. Yamanaka, S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell, 1(1), 39–49.
48. Miura, K., Okada, Y., Aoi, T., Okada, A., Takahashi, K., Okita, K., Nakagawa, M., Koyanagi, M., Tanabe, K., Ohnuki, M., Ogawa, D., Ikeda, E., Okano, H., & Yamanaka, S. (2009). Variation in the safety of induced pluripotent stem cell lines. Nature Biotechnology, 27(8), 743–745.
49. Wyles, S. P., Yamada, S., Oommen, S., Maleszewski, J. J., Beraldi, R., Martinez-Fernandez, A., Terzic, A., & Nelson, T. J. (2014). Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells and: Development.
50. Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., Noble, R. J., Packer, M., Silver, M. A., Stevenson, L. W., Gibbons, R. J., Antman, E. M., Alpert, J. S., Faxon, D. P., Fuster, V., Jacobs, A. K., Hiratzka, L. F., Russell, R. O., & Smith, S. C., Jr. (2001). ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation, 104(24), 2996–3007.
51. Xin, M., Olson, E. N., & Bassel-Duby, R. (2013). Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nature Reviews Molecular Cell Biology, 14(8), 529–541.
52. Aderem, A. (2005). Systems biology: its practice and challenges. Cell, 121(4), 511–513.
53. Caron, H., van Schaik, B., van der Mee, M., Baas, F., Riggins, G., van Sluis, P., Hermus, M. C., van Asperen, R., Boon, K., Voute, P. A., Heisterkamp, S., van Kampen, A., & Versteeg, R. (2001). The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science, 291(5507), 1289–1292.
54. Martinez-Fernandez, A., Li, X., Hartjes, K. A., Terzic, A., & Nelson, T. J. (2013). Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines. Circulation. Cardiovascular Genetics, 6(5), 462–471.
55. Bruneau, B. G. (2013). Signaling and transcriptional networks in heart development and regeneration. Cold Spring Harbor Perspectives in Biology, 5(3), a008292.
56. Faustino, R. S., Behfar, A., Perez-Terzic, C., & Terzic, A. (2008). Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biology, 9(1), R6.
57. Nelson, T. J., Faustino, R. S., Chiriac, A., Crespo-Diaz, R., Behfar, A., & Terzic, A. (2008). CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells, 26(6), 1464–1473.
58. Behfar, A., Perez-Terzic, C., Faustino, R. S., Arrell, D. K., Hodgson, D. M., Yamada, S., Puceat, M., Niederlander, N., Alekseev, A. E., Zingman, L. V., & Terzic, A. (2007). Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. Journal of Experimental Medicine, 204(2), 405–420.
59. Gersh, B. J., Simari, R. D., Behfar, A., Terzic, C. M., & Terzic, A. (2009). Cardiac cell repair therapy: a clinical perspective. Mayo Clinic Proceedings, 84(10), 876–892.
60. Olson, E. N., & Schneider, M. D. (2003). Sizing up the heart: development redux in disease. Genes & Development, 17(16), 1937–1956.
61. Xu, C., Police, S., Hassanipour, M., & Gold, J. D. (2006). Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells and Development, 15(5), 631–639.
62. Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M. (2008). Human cardiovascular progenitor cells develop from a KDR + embryonic-stem-cell-derived population. Nature, 453(7194), 524–528.
63. High, F. A., & Epstein, J. A. (2008). The multifaceted role of Notch in cardiac development and disease. Nature Reviews Genetics, 9(1), 49–61.
64. Rentschler, S., Yen, A. H., Lu, J., Petrenko, N. B., Lu, M. M., Manderfield, L. J., Patel, V. V., Fishman, G. I., & Epstein, J. A. (2012). Myocardial Notch signaling reprograms cardiomyocytes to a conduction-like phenotype. Circulation, 126(9), 1058–1066.
65. Cai, W., Guzzo, R. M., Wei, K., Willems, E., Davidovics, H., & Mercola, M. (2012). A Nodal-to-TGFbeta cascade exerts biphasic control over cardiopoiesis. Circulation Research, 111(7), 876–881.
66. Li, X., Martinez-Fernandez, A., Hartjes, K. A., Kocher, J. P., Olson, T. M., Terzic, A., & Nelson, T. J. (2014). Transcriptional Atlas of Cardiogenesis Maps Congenital Heart Disease Interactome. Physiology: Genomics.
67. Terami, H., Hidaka, K., Shirai, M., Narumiya, H., Kuroyanagi, T., Arai, Y., Aburatani, H., & Morisaki, T. (2007). Efficient capture of cardiogenesis-associated genes expressed in ES cells. Biochemical and Biophysical Research Communications, 355(1), 47–53.
68. Behfar, A., & Terzic, A. (2007). Cardioprotective repair through stem cell-based cardiopoiesis. Journal of Applied Physiology, 103(4), 1438–1440.
69. Ross, R. S., & Borg, T. K. (2001). Integrins and the myocardium. Circulation Research, 88(11), 1112–1119.
70. Schlesinger, J., Schueler, M., Grunert, M., Fischer, J. J., Zhang, Q., Krueger, T., Lange, M., Tonjes, M., Dunkel, I., & Sperling, S. R. (2011). The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genetics, 7(2), e1001313.
71. Wang H, Zhang Q, Fang X (2014) Transcriptomics and proteomics in stem cell research. Frontiers in Medicine.
72. Van Hoof, D., Heck, A. J., Krijgsveld, J., & Mummery, C. L. (2008). Proteomics and human embryonic stem cells. Stem Cell Research, 1(3), 169–182.
73. Baharvand, H., Hajheidari, M., Zonouzi, R., Ashtiani, S. K., Hosseinkhani, S., & Salekdeh, G. H. (2006). Comparative proteomic analysis of mouse embryonic stem cells and neonatal-derived cardiomyocytes. Biochemical and Biophysical Research Communications, 349(3), 1041–1049.
74. Cao, F., Wagner, R. A., Wilson, K. D., Xie, X., Fu, J. D., Drukker, M., Lee, A., Li, R. A., Gambhir, S. S., Weissman, I. L., Robbins, R. C., & Wu, J. C. (2008). Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS ONE, 3(10), e3474.
75. Yin, X., Mayr, M., Xiao, Q., Wang, W., & Xu, Q. (2006). Proteomic analysis reveals higher demand for antioxidant protection in embryonic stem cell-derived smooth muscle cells. Proteomics, 6(24), 6437–6446.
76. Mayr, M., Madhu, B., & Xu, Q. (2007). Proteomics and metabolomics combined in cardiovascular research. Trends in Cardiovascular Medicine, 17(2), 43–48.
77. Prudhomme, W., Daley, G. Q., Zandstra, P., & Lauffenburger, D. A. (2004). Multivariate proteomic analysis of murine embryonic stem cell self-renewal versus differentiation signaling. Proceedings of the National Academy of Sciences of the United States of America, 101(9), 2900–2905.
78. Arrell, D. K., Niederlander, N. J., Perez-Terzic, C., Chung, S., Behfar, A., & Terzic, A. (2007). Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics. Clinical Pharmacology & Therapeutics, 82(3), 316–319.
79. Arrell, D. K., Niederlander, N. J., Faustino, R. S., Behfar, A., & Terzic, A. (2008). Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells, 26(2), 387–400.
80. Chiriac, A., Nelson, T. J., Faustino, R. S., Behfar, A., & Terzic, A. (2010). Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network. PLoS ONE, 5(4), e9943.
81. Fraidenraich, D., Stillwell, E., Romero, E., Wilkes, D., Manova, K., Basson, C. T., & Benezra, R. (2004). Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells. Science, 306(5694), 247–252.
82. Doss, M. X., Chen, S., Winkler, J., Hippler-Altenburg, R., Odenthal, M., Wickenhauser, C., Balaraman, S., Schulz, H., Hummel, O., Hubner, N., Ghosh-Choudhury, N., Sotiriadou, I., Hescheler, J., & Sachinidis, A. (2007). Transcriptomic and phenotypic analysis of murine embryonic stem cell derived BMP2+ lineage cells: an insight into mesodermal patterning. Genome Biology, 8(9), R184.
83. Bader, A., Al-Dubai, H., & Weitzer, G. (2000). Leukemia inhibitory factor modulates cardiogenesis in embryoid bodies in opposite fashions. Circulation Research, 86(7), 787–794.
84. Prigione, A., Fauler, B., Lurz, R., Lehrach, H., & Adjaye, J. (2010). The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells, 28(4), 721–733.
85. Folmes, C. D., Martinez-Fernandez, A., Perales-Clemente, E., Li, X., McDonald, A., Oglesbee, D., Hrstka, S. C., Perez-Terzic, C., Terzic, A., & Nelson, T. J. (2013). Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells, 31(7), 1298–1308.
86. Chung, S., Arrell, D. K., Faustino, R. S., Terzic, A., & Dzeja, P. P. (2010). Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. Journal of Molecular and Cellular Cardiology, 48(4), 725–734.
87. Patti, G. J., Yanes, O., & Siuzdak, G. (2012). Innovation: Metabolomics: the apogee of the omics trilogy. Nature Reviews Molecular Cell Biology, 13(4), 263–269.
88. Folmes, C. D., Nelson, T. J., Martinez-Fernandez, A., Arrell, D. K., Lindor, J. Z., Dzeja, P. P., Ikeda, Y., Perez-Terzic, C., & Terzic, A. (2011). Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metabolism, 14(2), 264–271.
89. Panopoulos, A. D., Yanes, O., Ruiz, S., Kida, Y. S., Diep, D., Tautenhahn, R., Herrerias, A., Batchelder, E. M., Plongthongkum, N., Lutz, M., Berggren, W. T., Zhang, K., Evans, R. M., Siuzdak, G., & Izpisua Belmonte, J. C. (2012). The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Research, 22(1), 168–177.
90. Ezashi, T., Das, P., & Roberts, R. M. (2005). Low O2 tensions and the prevention of differentiation of hES cells. Proceedings of the National Academy of Sciences of the United States of America, 102(13), 4783–4788.
91. Westfall, S. D., Sachdev, S., Das, P., Hearne, L. B., Hannink, M., Roberts, R. M., & Ezashi, T. (2008). Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. Stem Cells and Development, 17(5), 869–881.
92. Mohyeldin, A., Garzon-Muvdi, T., & Quinones-Hinojosa, A. (2010). Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell, 7(2), 150–161.
93. Chung, S., Dzeja, P. P., Faustino, R. S., Perez-Terzic, C., Behfar, A., & Terzic, A. (2007). Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nature Clinical Practice. Cardiovascular Medicine, 4(Suppl 1), S60–67.
94. Cho, Y. M., Kwon, S., Pak, Y. K., Seol, H. W., Choi, Y. M., do Park, J., Park, K. S., & Lee, H. K. (2006). Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochemical and Biophysical Research Communications, 348(4), 1472–1478.
95. Suresh, R., Li, X., Chiriac, A., Goel, K., Terzic, A., Perez-Terzic, C., & Nelson, T. J. (2014). Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction. Journal of Molecular and Cellular Cardiology, 74C, 13–21.
96. Bolli, R., Chugh, A. R., D'Amario, D., Loughran, J. H., Stoddard, M. F., Ikram, S., Beache, G. M., Wagner, S. G., Leri, A., Hosoda, T., Sanada, F., Elmore, J. B., Goichberg, P., Cappetta, D., Solankhi, N. K., Fahsah, I., Rokosh, D. G., Slaughter, M. S., Kajstura, J., & Anversa, P. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet, 378(9806), 1847–1857.
97. Bartunek, J., Vanderheyden, M., Hill, J., & Terzic, A. (2010). Cells as biologics for cardiac repair in ischaemic heart failure. Heart, 96(10), 792–800.
98. Behfar, A., Crespo-Diaz, R., Terzic, A., & Gersh, B. J. (2014). Cell therapy for cardiac repair–lessons from clinical trials. Nature Reviews Cardiology, 11(4), 232–246.
99. Makkar, R. R., Smith, R. R., Cheng, K., Malliaras, K., Thomson, L. E., Berman, D., Czer, L. S., Marban, L., Mendizabal, A., Johnston, P. V., Russell, S. D., Schuleri, K. H., Lardo, A. C., Gerstenblith, G., & Marban, E. (2012). Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet, 379(9819), 895–904.
100. Terzic, A., & Behfar, A. (2014). Regenerative heart failure therapy headed for optimization. European Heart Journal, 35(19), 1231–1234.
101. Dimmeler, S., & Zeiher, A. M. (2009). Cell therapy of acute myocardial infarction: open questions. Cardiology, 113(3), 155–160.
102. Wollert, K. C., & Drexler, H. (2010). Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nature Reviews Cardiology, 7(4), 204–215.
103. Behfar, A., Crespo-Diaz, R., Nelson, T. J., Terzic, A., & Gersh, B. J. (2010). Stem cells: clinical trials results the end of the beginning or the beginning of the end? Cardiovascular & Hematological Disorders-Drug Targets, 10(3), 186–201.
104. Ellison, G. M., Nadal-Ginard, B., & Torella, D. (2012). Optimizing Cardiac Repair and Regeneration Through Activation of the Endogenous Cardiac Stem Cell Compartment. Journal of Cardiovascular Translational: Research.
105. Nadal-Ginard, B., Ellison, G. M., & Torella, D. (2014). The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult. Stem Cell: Research.